HEALTH SYSTEM CHANGES TO ADDRESS RISK FACTORS IN CANCER Solicitation ID/Procurement Identifier: 75D301-20-Q-71751 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2023
NCI is going to use the available data and biospecimens from this study for the analysis of risk factors and correlates of gastric cancer.
on ovarian cancers and/or related gynecologic cancers.
A SOLICITATION WILL BE ISSUED ON A LATER DATE.Title: Integrative Epidemiological StudiesDescription:The National Cancer Institute (NCI), Integrative Tumor Epidemiology Branch (ITEB) advances the understanding of cancer etiology and progression through integrative analyses of environmental and germline risk factors with comprehensive data on histological and molecular profiling of tumors and their precursors, including somatic genomic analyses.
Pursuant to FAR Subpart 13.106-1(b)(1), Regional Health Contracting Office-Central, Fort Carson Health Contracting Cell/WBAMC LNO, intends to issue a sole source award to Genomic Health, Inc. to provide recurrence risk testing for patients that have been diagnosed with breast cancer (Oncotype DX), recurrence risk testing for patients that have been diagnosed with colorectal cancer (Oncotype DX) and the favorable intermediate risk factors patients
More recently, the onset of the ‘omics age and precision medicine has compelled many Agencies and Institutions to encourage collaborations across existing large cancer cell line panels. Such a collaborative approach enables the development of studies large enough to address the dynamic and interactive nature of the factors underlying cancer development and pharmacological response.
See attached PDF.
